Acumen Pharmaceuticals - Stock Price History | ABOS

Historical daily share price chart and data for Acumen Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Acumen Pharmaceuticals as of October 15, 2021 is 13.55.
  • The all-time high Acumen Pharmaceuticals stock closing price was 20.28 on July 02, 2021.
  • The Acumen Pharmaceuticals 52-week high stock price is 26.98, which is 99.1% above the current share price.
  • The Acumen Pharmaceuticals 52-week low stock price is 12.70, which is 6.3% below the current share price.
  • The average Acumen Pharmaceuticals stock price for the last 52 weeks is 16.29.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Acumen Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.564B $0.001B
Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.216B 8.54
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.812B 20.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.815B 0.00
Emergent Biosolutions (EBS) United States $2.763B 6.66
Arcus Biosciences (RCUS) United States $2.321B 0.00
Myovant Sciences (MYOV) United Kingdom $1.993B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.769B 0.00
Zymeworks (ZYME) Canada $1.152B 0.00
Ambrx Biopharma (AMAM) United States $0.431B 0.00
SQZ Biotechnologies (SQZ) United States $0.346B 0.00
Enzo Biochem (ENZ) United States $0.188B 18.43